Abstract Sphingolipids are constituents of cellular membranes and play important roles as second messengers mediating cell functions. As significant components in foods, sphingolipids have been proven to be critical for human health. Moreover, diverse metabolic intermediates of sphingolipids are known to play key roles both in proinflammatory and in anti-inflammatory effects. However, the effect of dietary sphingolipids on inflammation is a complicated field that needs to be further assessed. Our study evaluated the effects of orally administered maize glucosylceramide (GluCer), one of the most conventional dietary sphingolipids, on inflammation using the 2,4-dinitro-1-fluorobenzene-treated BALB/c murine model. Oral administration of GluCer inhibited ear swelling and leukocyte infiltration to the inflammatory site, suggesting that dietary GluCer has anti-inflammatory properties. ELISA analyses revealed that oral administration of GluCer for 6 days had not modified the Th1/Th2 balance, but significantly downregulated the activation of TNF-a at the inflammatory site. Based on these results, the down-regulation of TNF-a by dietary GluCer may suppress vascular permeability and reduce the migration of inflammatory cells. Our findings increase understanding of the actions of dietary sphingolipids on the balance of the immune response.
Abbreviations

DNFB 2,4-Dinitro-1-fluorobenzene
Interleukin-4 IL-6
Interleukin-6 NF-jB Receptor activator of nuclear factor-kappa B Th1
T-helper 1 Th2
T-helper 2 TNF-a Tumor necrosis factor-alpha
Introduction
Sphingolipids are commonly believed to protect the cell surface against harmful environmental factors by forming the mechanically stable and chemically resistant outer leaflet of the plasma membrane lipid bilayer [1] [2] [3] [4] . Sphingolipids generate diverse metabolic intermediates, notably ceramide, sphingosine, sphingosine-1-phosphate, and ceramide-1-phosphate, which serve as important mediators in the signaling cascades involved in apoptosis, proliferation, and stress responses [5] [6] [7] [8] . Although we have already demonstrated that dietary sphingolipids are poorly absorbed by the intestine [9] , sphingolipids that are significant components of foods have gained considerable attention for their potential and essential roles in human health [10] [11] [12] [13] [14] . It has been reported that dietary supplementation with sphingolipids has diverse physiological effects, such as lowering plasma lipids [15] , improving the skin barrier function [16] , preventing melanin formation [17] , contributing to central nervous system myelination [18] as well as protecting the colon against inflammation [19] [20] [21] [22] [23] [24] [25] . However, the functional, regulatory, and physiological significance of the immune regulating effects of dietary sphingolipids is an appreciably complicated field that is not well understood.
One hypothesis of immune regulation involves the balance between T-helper 1 (Th1) and T-helper 2 (Th2) cells, which direct different immune response pathways. Th1 cells drive the ''cellular immunity'' pathway to fight viruses and other intracellular pathogens, eliminate cancer cells, and stimulate delayed-type hypersensitivity skin reactions. Th2 cells are involved in ''humoral immunity'' and up-regulate antibody production to fight extracellular organisms. Either pathway can down-regulate the other. Disruption of the Th1/Th2 balance can cause immunological diseases [26, 27] . Via the actions of sphingolipid degrading enzymes, such as sphingomyelinase, glycoceramidases, and ceramidase, dietary sphingolipids are hydrolyzed to various kinds of metabolic intermediates which are critical for the activation and mediation of various types of immune cells. Metabolites of sphingolipids initiate and maintain diverse aspects of immune cell balance and functional responses by regulating cell migration and inflammatory pathways [8, 20, [28] [29] [30] [31] . For instance, sphingolipid hydrolysis products regulate cyclooxygenase-2, interleukin 1b (IL-1b), interleukin 6 (IL-6), tumor necrosis factor a (TNF-a) and nuclear factor kappa B (NF-jB) via the sphingosine kinase 1/sphingosine-1-phosphate and ceramide kinase 1/ceramide-1-phosphate pathways, and thus cause the activation of mast cells, control thymocyte maturation and regulate the balance of lymphocyte subpopulations [32] [33] [34] [35] [36] [37] .
The goal of this study was to evaluate the effects of orally administered glucosylceramide (GluCer), one of the most important dietary sphingolipids, against DNFBinduced ear swelling in the BALB/c murine model, to provide further understanding of how dietary sphingolipids act on the balance between proinflammatory and antiinflammatory responses.
Materials and Methods
Maize GluCer Preparation
GluCer from maize was kindly donated by Nippon Flour Mills Co. Ltd. (Atsugi, Japan). The purity of this GluCer was 96%, which was determined by HPLC equipped with an evaporative light-scattering detector, as described previously [12] .
Animals
Female BALB/c mice (6 weeks old, 15-20 g body weight) were purchased from Japan SLC Inc. (Shizuoka, Japan). Animals were group-housed at six mice per cage, and were bred at the Institute's animal facilities at 25°C with a 12-h light/dark cycle. Pure water and AIN-93G diet (Oriental Yeast Co., Ltd., Tokyo, Japan) were available ad libitum. All experiments were performed according to the guidelines of Kyoto University for the use and care of laboratory animals.
Contact Hypersensitivity Induced by DNFB After a 2-week acclimatization period, allergic contact dermatitis was induced by DNFB in BALB/c mice according to a previously published method with minor modifications [38] . Briefly, mice were sensitized on day 0 by application of 100 ll 0.5% DNFB in acetone-soybean oil (4:1, v/v) on their shaved dorsal skin. The mice were divided into control, low dose (5 mg) and high dose (50 mg) groups (n = 12 in each group). An identifying mark was made on the tail of each mouse.
The maize GluCer was suspended in 0.5% carboxymethyl cellulose (CMC) (Nacalai Tesque Co. Ltd., Kyoto, Japan) solution and was orally administered at 5 or 50 mg to each mouse daily for 6 days. One hour after the final treatment, mice were challenged with 20 lL 0.5% DNFB in acetone-soybean oil (4:1) on both ears. The thickness of the right ear of each mouse was measured with a Dial Thickness Gauge (Mitutoyo Co., Kanagawa, Japan) at 0, 6 and 24 h after the DNFB challenge. Ear swelling was calculated as the difference in thickness before and after challenge [39] .
Six hours (n = 6) and 24 h (n = 6) after DNFB treatment, blood was collected and mice were sacrificed under anesthesia. The right ear and spleen of each mouse was immediately excised and frozen in liquid nitrogen, then stored at -80°C until use.
Morphological Analysis
The left ear of each mouse was fixed in 10% neutral buffered formalin solution and was then processed routinely into paraffin wax. Formalin fixed paraffin sections were stained with hematoxylin and eosin (H&E) to observe morphological changes using a microscope (Keyence Co., Osaka, Japan).
Measurement of Cytokine Production and Serum Immunoglobulin E
Amounts of IFN-c, interleukin-4 (IL-4), TNF-a and interleukin-10 (IL-10) in homogenates of tissues were quantified using Murine IL-4 (Diaclone Research, Besancon, France), Murine IFN-c (Diaclone Research), Mouse TNF-a (Pierce Biotechnology Inc., Rockford, IL, USA), and Murine IL-10 (Diaclone Research) ELISA kits, respectively, according to the manufacturer's instructions. Levels of those cytokines in each supernatant were normalized to total protein content, which was determined using a DC Protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Total serum IgE levels of DNFB-challenged mice were quantified using a Mouse IgE ELISA kit (Immunology Consultants Laboratory, Newberg, ON, USA) according to the manufacturer's instructions.
Statistical Analysis
Data are reported as means ± SD. Statistical analyses were performed using one-way analysis of variance (ANOVA) with Fisher's PLSD method to identify levels of significance between the groups.
Results
GluCer Suppresses DNFB-Induced Ear Swelling of BALB/c Mice
After challenge with DNFB, typical allergic contact dermatitis was provoked in the ears of BALB/c mice, which was characterized by an initial increase in ear thickness and visible congestion of blood vessels. Oral treatment with maize GluCer suppressed DNFB-induced inflammatory symptom (redness and thickness) of ears. As shown in Fig. 1a significant depression of ear thickness was observed at 6 h in both low (5 mg/day) and high dose (50 mg/day) GluCer treated groups (p \ 0.05). At 24 h, the average value of ear thickness was also reduced by GluCer, but there were no statistical differences among the three groups, which may due to large individual differences. The reduction of DNFB-induced ear swelling implies dietary GluCer has anti-inflammatory property.
GluCer Inhibits Inflammatory Infiltrates in the Ears of BALB/c Mice
Histological specimens of ears were prepared at 6 and 24 h after topical application of DNFB in BALB/c mice. In the control group, typical allergic contact dermatitis with congested blood vessels and apparent edema could be observed by H&E staining. As shown in Fig. 2a, b , microvascular dilations and dense leukocytes infiltrating the connective tissue, which are characteristics of inflammatory reactions, were clearly observed in the control group. At higher magnification, various kinds of migrated inflammatory cells could also be observed, including fibrocytes, mononuclear cells, degranulated mast cells and other leukocytes. These results confirm that DNFB induces severe inflammation in the ears of BALB/ c mice and that a variety of lymphocytes migrated out from blood vessels during this contact sensitivity procedure. In both the low (5 mg/day) and the high (50 mg/ day) dose GluCer-treated groups, microvascular dilation and leukocytes in inflammatory infiltrates were inhibited at 6 h (Fig. 2b, c ) and 24 h groups (Fig. 2e, f) . These results show that dietary GluCer inhibits microvascular dilation and inflammatory infiltration of DNFB-induced BALB/c mice.
GluCer Inhibits Inflammation by Reducing TNF-a Production in the Ear
To clarify the effect of GluCer on DNFB-induced inflammation, especially on Th1/Th2 balance, levels of IFN-c as an indicator of Th1 cells and IL-4 as an indicator of Th2 cells were measured by ELISA assay. IFN-c and IL-4 levels of GluCer-treated group were not significantly altered (Table 1) . In other words, Th1/Th2 balance was not modified by oral administration of GluCer for 6 days. For further evaluating the effect of GluCer on DNFBinduced inflammation, IL-10 was determined. In ear, IL-10 was significantly decreased at 6 h both low and high dose groups, whereas this effect did not prolong to 24 h (Table 1) . However, in spleen, IL-10 was increased by GluCer treatment at 24 h, but not reached a statistical significance in 6 h because of the relatively large individual differences (Table 1) .
TNF-a as the most important proinflammatory cytokine and IgE as the most important antibody in the serum were also measured. As shown in Fig. 3a , the TNF-a level in the ear was significantly suppressed both in the low and high dose GluCer groups (p \ 0.05). Moreover, TNF-a level was also significantly down-regulated at 24 h by the effect of high dose GluCer (Fig. 3b) . In contrast, IgE in the serum was almost at the same level among the control, low and high GluCer dose groups (Fig. 3c, d) . The anti-inflammatory effect of dietary GluCer on contact dermatitis in DNFB-induced BALB/c mice is via regulation of the level of TNF-a secreted by inflammatory cells in the ear. 
Discussion
The findings presented here indicate that dietary plant GluCer, one of the most important and abundant sphingolipids in food [12] , suppresses the DNFB-induced ear swelling of BALB/c mice, and inhibits the microvascular dilation and inflammatory infiltration response via downregulating levels of TNF-a, but not modifying the balance of Th1/Th2. Meanwhile, over-expressed IL-10 in inflammatory ear skin was suppressed by dietary GluCer. This anti-inflammatory effect of dietary GluCer increases our understanding of biofunctional sphingolipids. Dietary GluCer is known to be hydrolyzed to ceramide, sphingosine and free fatty acids in the intestinal lumen. In mucosal cells, exogenous free sphingosine and dihydrosphingosine are rapidly absorbed and metabolized to palmitic acid [40] . A smaller portion of the sphingoid bases is reincorporated into ceramide and more complex sphingolipids. Our recent findings revealed that dietary GluCer originating from higher plants can be hydrolyzed in the intestine and that the intact plant form of sphingoid bases is barely absorbed by the tissues [9, 41] . Ono et al. [42] reported that dietary maize and yeast GluCer did not alter the sphingoid base composition in the skin of NC mice. We speculate that dietary maize GluCer accomplishes its anti-inflammatory effect, not only by producing bio-active metabolic intermediates through the sphingolipid metabolic pathways, but also via the activation of sphingolipid metabolic enzymes that affect endogenous sphingolipids at the inflammatory site, because diverse metabolic intermediates of sphingolipids, including ceramide, sphingosine, sphingosine-1-phosphate and ceramide-1-phosphate are well known important and highly bioactive endogenous regulators, which are involved in a complex metabolism network and play critical roles in inflammation [43] [44] [45] [46] .
In the case of our study, dietary maize GluCer accomplishes its inhibition of inflammation via the down-regulation of TNF-a level at the inflammatory site. TNF-a, produced by mononuclear phagocytes and other inflammatory cells (neutrophils, lymphocytes, natural killer cells, and mast cells) or non-inflammatory cells (endothelial cells), is known to be one of the most important inflammatory mediators [47, 48] . TNF-a facilitates the formation of adhesion molecules, vascular permeability and migration of leukocytes to sites of inflammation by affecting endothelial cells [49] [50] [51] . Our results reveal that dietary maize GluCer downregulates levels of TNF-a in inflammatory ears. This downregulation of TNF-a may affect endothelial cells and inflammatory cells, and also can inhibit vascular permeability at the site of inflammation. As a result, leukocyte migration is reduced. In the inflammatory cells, DNFB activates NF-jB by depredating the inhibitor of NF-jB (IjB) [52] . In addition, it has been reported that sphingolipids down regulated TNF-a via inactivating of NF-jB in histamine-induced mouse skin tissues [53] . Thus, dietary GluCer seems to inhibit the DNFB activated NF-jB and down-modulate TNF-a expression in this study. Moreover, IL-10 levels were increased in spleens but suppressed in ears by dietary GluCer. This well known anti-inflammatory cytokine, IL-10, has been reported overexpressed during the antigen-specific type of skin inflammation [54] and DNFB-challenged ear [55, 56] . IL-10 is released by CD4? T helper 2 (Th2) cell clones and a variety of other cells, including keratinocytes, macrophages, B lymphocytes, and mast cells [56] . The suppressive effect of dietary GluCer on IL-10 expression in DNFB-challenged ears might be caused by the inhibition of leukocytes infiltrating to inflammatory site.
Ono et al. [42] demonstrated that supplementation of 0.1% GluCer diet for 7-week prevented atopic dermatitislike symptoms in a mouse model by regulating the Th1/ Th2 balance. However, IFN-c, IL-4 and IgE levels, the markers of Th1/Th2 balance, were not notably affected by GluCer administration for 6 days in the present study. It appears that the period of treatment is important for immunological response of dietary GluCer.
Furthermore, allergic inflammatory skin disease is associated with a loss of ceramide in the extracellular lamellar membranes which causes an abnormal barrier function of the stratum corneum [57] . Application of ceramide on diseased skin could significantly reduce allergic inflammatory reactions by improving the severity score, stratum corneum cohesion and hydration [58] [59] [60] . Dietary GluCer might also improve the stratum corneum cohesion and hydration of ear skin to reduce the skin inflammation.
In summary, our data provide evidence that maize GluCer has anti-inflammatory effects on the DNFBinduced inflammation of BALB/c mice. We confirmed that dietary GluCer inhibits ear swelling and leukocyte infiltration. Furthermore, our results indicate that this effect is accomplished mainly by down-regulating TNF-a, but does not significantly affect Th1/Th2 balance or IgE levels in the serum. We hypothesize that dietary GluCer accomplishes its anti-inflammatory effect by down-regulating TNF-a to suppress vascular permeability. This reduces the migration of inflammatory cells, affects endogenous sphingolipids through metabolic pathways by activating sphingolipidrelated enzymes, and moreover, by hydrolysis to ceramide to improve skin barrier function at the dermatitis site. Our findings increase the comprehensive understanding of the actions of dietary sphingolipids on the balance of immune responses.
